Industry Conference

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

Chinese firm launches durable centrifuges for sub-zero climates and announces a major localization strategy to capture a multi-billion dollar market.

After a turbulent year, the sleep apnea device maker aims to prove its rocky product launch is behind it and convince investors of a strong 2026.

Goodix's new GR5410 chip uses Bluetooth 6.1 and Channel Sounding to enable ultra-secure, high-precision digital car keys that can defeat relay attacks.

Lotusia Group's Co-CEO Jacob Tao spearheads an ambitious expansion into digital compliance and wealth management while championing impactful social initiatives.

The Channel Partners 2026 conference will address the rapid pace of AI and market shifts with its 'Channel Velocity' theme and a Robert Irvine keynote.

The biotech upstart will present a bold pipeline, including a head-to-head trial against a market leader and a first-in-class autoimmune eye disease therapy.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

Global agency INVNT appoints its first Chief AI Officer, betting on a unique human-centric leader to navigate the AI revolution in brand storytelling.

Comedian Gabriel Iglesias hosts a new fan-voted awards show for pets, blending Hollywood glamour with a major charitable mission for animal welfare.

Haier's immersive festival in KL isn't just about new gadgets. It's a strategic play for brand loyalty in Malaysia's booming smart home market.

NorthStar Medical Radioisotopes will showcase its revolutionary cancer-fighting isotopes, Ac-225 and Cu-67, at the prestigious J.P. Morgan conference.

A Chinese dance drama fusing martial arts and contemporary dance earns global acclaim, bridging cultural divides from Shenzhen to its sold-out Toronto debut.

Armed with breakthrough data on an AI-designed therapy that penetrates the brain, Rakovina Therapeutics heads to JPM Week to court major partners.

A new AI-powered smart console wowed crowds at INTERMOT, attracting interest from Yamaha and Honda and signaling a major shift in motorcycle technology.

An Indiana biotech prepares for biotech's biggest stage, showcasing a pipeline that offers new hope for chronic endocrine and metabolic disorders.

Beyond vaccines, Strand Therapeutics' programmable mRNA shows stunning success in late-stage cancer, heralding a new age of logic-driven genetic medicine.

A new AI system deters birds to prevent avian flu. But its real innovation lies in data, transforming biosecurity from a costly chore into a profitable investment.

Beyond the runway hype, AI is now a core driver of commerce. But does it level the playing field or just raise the stakes for everyone involved?

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.